A 60-year-old man presents to the urology clinic to establish care and discuss prostate cancer screening. He is in excellent health with no lower urinary tract symptoms. Arrange the following interventions in the most appropriate chronological order, representing the standard clinical pathway from initial screening to potential definitive surgical management for localized prostate cancer.
- 1Measurement of serum prostate-specific antigen (PSA) level and digital rectal examination (DRE)
- 2Multiparametric magnetic resonance imaging (mpMRI) of the prostate
- 3Transrectal ultrasound (TRUS) guided systematic and MRI-targeted prostate biopsy
- 4Robot-assisted laparoscopic radical prostatectomy
Answer
The correct sequence is: initial screening (PSA and DRE), followed by imaging (mpMRI), then tissue diagnosis (targeted biopsy), and finally definitive surgical treatment (radical prostatectomy).
The contemporary management pathway for localized prostate cancer follows a strict sequence to maximize diagnostic accuracy and avoid unnecessary interventions. It begins with screening using serum PSA and DRE. If risk is elevated, guidelines now recommend performing a multiparametric MRI (mpMRI) prior to biopsy. This imaging identifies suspicious lesions and allows for targeted tissue sampling. Subsequently, a prostate biopsy (e.g., TRUS-guided) is performed to obtain a definitive histopathological diagnosis and Gleason grade. Only after tissue confirmation of malignancy is definitive surgical management, such as a radical prostatectomy, offered to appropriate surgical candidates.
Step-by-Step Solution
Key Concept
The standard diagnostic and therapeutic pathway for localized prostate cancer.